Objective: We investigated gay and bisexual men's willingness to selfadminister an anal cancer screening test at home.
2,3
The majority (>70%) of cases of anal cancer are associated with human papillomavirus (HPV) infection, specifically with high-risk type 16 or 18. 4 Risk factors for new or persistent anal HPV infections include anal intercourse, having multiple sexual partners, and smoking. 5 These risk factors may explain why high-risk HPV types are common in HIV-negative and HIVpositive MSM (12.5% and 35.4%, respectively, for type 16). 3 Anal cytological screening and treatment of dysplastic lesions could represent an important strategy for preventing anal cancer. 6 Routine cervical Papanicolaou (Pap) testing has resulted in a dramatic decrease in the incidence of invasive cervical cancer in women over the last 50 years. 7 It is possible that anal cancer screening could have similar effects for MSM, given the similarities between cervical and anal cancers and studies showing anal cytology (Pap) tests have similar accuracy to cervical Pap tests. 8 However, no studies have been conducted to determine anal cancer screening's effect on mortality or other patient-centered outcomes. 9 Despite this uncertainty, some clinicians are now recommending high-risk men, including HIV-positive MSM, be screened for anal cancer because of the high incidence of anal cancer. 10, 11 Studies of anal cancer screening behavior among MSM have focused almost exclusively on men's acceptance of physiciancollected Pap tests. 12 Self-collected anal Paps have been shown to have accuracy similar to clinician-collected tests. 13 Studies of self-tests for HIV and other sexually transmitted diseases have found high rates of acceptability among MSM, and it is possible that allowing men to use a self-test for anal cancer would increase screening uptake. 14, 15 The purpose of the present study was to examine gay and bisexual men's willingness to use a self-collected anal cancer screening test at home and to identify correlates of willingness to use a self-test. Findings could help inform future programs for promoting anal cancer screening among this higherrisk population.
METHODS
We report data from 2 separate cross-sectional studies of gay and bisexual men. The studies are described in detail elsewhere and briefly here. 16 
Study I

Sample and Procedures
The sample for Study I came from an existing national panel of US households maintained by Knowledge Networks (Palo Alto, CA). Panel members were recruited using list-assisted random-digit dialing. Panel members received free Internet access or small cash payments in exchange for completing surveys. Study I was limited to men aged 18 to 59 and oversampled for self-identified gay and bisexual men. Of the 874 eligible panel members invited to participate, 609 (70%) consented to and completed the survey in January 2009. Of those who completed the survey, 306 men self-identified as gay (n = 236) or bisexual (n = 70) and were included in the current analysis. The institutional review board at the University of North Carolina approved this study.
Measures
The Study I survey is available online at www.unc.edu/~ntbrewer/ hpv.htm. We developed the survey items based on our previous work on HPV-related diseases. 18, 19 Our primary outcome was willingness to self-administer an anal cancer screening test at home. Introductory text to the section on anal cancer screening read, "Doctors can use an anal Pap test to identify anal cancer. An anal Pap test is when a doctor collects cells from the anus using a swab (like an extra-long Q-tip) and examines them for changes. An anal Pap test is not the same as a test for anal gonorrhea, a colonoscopy, or a digital rectal exam." The survey assessed willingness to get a physician-collected anal Pap test under 2 conditions: (1) if it were free and (2) if it cost $150 out of pocket. Then, the survey assessed willingness to selfadminister an anal cancer screening test: "How willing would you be to use an anal swab on yourself to screen for anal cancer? You would do this test at home by yourself instead of going to a doctor's office." Response options for willingness items were definitely would not, probably would not, not sure, probably would, and definitely would. We combined responses into two categories: willing (probably or definitely would) and not willing (all other responses).
The survey assessed participants' awareness of HPV before the study and knowledge of HPV using 5 factual items. We coded 3 to 5 correct responses as high HPV knowledge and the rest as low HPV knowledge, based on the median number of correct responses for the entire sample. The survey also measured respondents' perceived knowledge of several HPV-related diseases (genital warts, oral cancer, and anal cancer), as well their worry about the disease, perceived likelihood of developing it, and belief that having the disease would change their lives. Because pilot testing showed men had low familiarity with HPV-related disease, we included brief informative statements about each disease before asking questions about them.
We measured several demographic and health-related characteristics as potential covariates. We defined "urban" as living in a metropolitan statistical area based on zip code. The survey also asked about history of sexually transmitted infections, genital warts, lifetime number of sexual partners, number of partners in the past year, and whether participants had disclosed sexual behavior with men to their physician.
Study II
Sample and Procedures
The Study II sample was drawn from the Harris Interactive LGBT Panel, a subset of the Harris Poll Online Panel (Rochester, NY). The Harris Poll Online Panel is a voluntary research panel that includes members throughout the entire country; US participants are similar to the general population for several demographic characteristics. 20 Panel members who complete surveys receive points that can be exchanged for rewards. Inclusion criteria for Study II included being age 18 to 26 (because the primary focus of the study was on HPV vaccination among young adults); living in the United States; and self-identifying as lesbian, gay, bisexual, or transgender (LGBT). Of 2,014 eligible panel members, 1005 (50%) consented to and completed an online survey in October or November 2013. Of those who completed the survey, the 428 men who self-identified as gay (n = 309) or bisexual (n =119) were included in the current analysis. The institutional review board at The Ohio State University approved Study II.
Measures
We based the Study II survey on the survey used for Study I, as well as subsequent surveys on HPV vaccination. 21, 22 Our primary outcome was willingness to self-administer an anal cancer screening test at home. The survey item read, "There is also a home test that may help screen for anal cancer. This test would involve using a swab (like a Q-tip) to get an anal specimen. You would do this test at home by yourself instead of going to a doctor's office. How willing would you be to use an anal swab on yourself to screen for anal cancer?" As with Study I, the 5 response options were combined into willing to self-test (probably or definitely willing) and not willing (note sure, probably, or definitely not willing). An additional item asked participants to select potential concerns they had about using a home test for anal cancer from a list of predefined response options. The survey assessed participants' awareness of HPV before the study and knowledge of HPV using 5 factual items. We coded 4 or 5 correct responses as high HPV knowledge and less than 4 correct responses as low HPV knowledge, based on the median number correct for the entire sample. The survey also measured respondents' worry about and perceived seriousness of HPVrelated disease, as well as their perceived likelihood of developing specific diseases (genital warts, oral cancer, and anal cancer).
We measured several demographic and health-related characteristics as potential covariates. We defined "urban" as selfreport of living in an urban or suburban area. The survey also asked about history of sexually transmitted infections, genital warts, lifetime number of sexual partners, number of partners in the past year, and whether participants had disclosed their sexual orientation to their physician.
Analyses
We analyzed data from the 2 studies separately, given their different samples. We used logistic regression to identify bivariate correlates of willingness to self-administer an anal cancer screening test. We entered statistically significant (P < 0.05) bivariate correlates into multivariate logistic regression models for each study.
We used McNemar test to compare Study I participants' willingness to self-administer an anal cancer screening test to their willingness to get a physician collected anal cancer screening test that cost $150 or that was free. We used Pearson's chi-squared test to compare the 2 study samples' willingness to self-administer the test.
We analyzed data with Stata release 13 (StataCorp LP, 2013, College Station, TX). All statistical tests were 2-tailed, using a critical α = 0.05. Missing values were replaced using mean substitution.
The reporting of this paper conforms to the STROBE statement, and a completed STROBE checklist is available online (Supplemental Digital Content, Table 1 , http://links.lww.com/LGT/A17). 23 
Role of the Funding Source
RESULTS
Participant Characteristics
Most men in Study I identified as gay (77%) and were HIV negative (83%) ( Table 1) . Their median age was 47 years (range, 20-59), and 96% were older than 26. Most were non-Hispanic white (81%), had a college degree (56%), were insured (86%), or lived in an urban area (93%). Nearly half were married or living with a partner (48%), and most had at least 5 lifetime sexual partners (89%). Only 23% had ever heard of an anal Pap before the survey, and 14% reported having an anal Pap in the past.
A similar proportion of men in Study II identified as gay (72%). Almost all men in Study II were HIV negative (96%). 
Willingness to Self-Administer an Anal Cancer Screening Test
Most men in Study I (78%; 95% confidence interval [CI], 73%-82%) were willing to self-administer an anal cancer screening test at home (Fig. 1 ). Men were somewhat less willing to selfadminister the test than to get a free physician-collected test (78% vs. 83%; χ 2 = 4.41; P = 0.04). They were much more willing to self-administer the test than to get a physician-collected test that cost $150 (78% vs. 31%; χ 2 = 129.60, P < 0.001). Two-thirds of Study II men (67%; 95% CI, 62%-71%) were willing to self-administer an anal cancer screening test at home, a lower percentage than among Study I participants (P < 0.001). The most common concerns about self-administrating the test that participants cited were "I might not do the test right" (61%) and "the test might not be accurate" (59%) (Fig. 2) . Approximately 29% of the men said they would rather go to a physician to get screened for anal cancer, 22% were concerned the test would hurt, and 17% thought it would be embarrassing.
Correlates of Willingness
In Study I, men's willingness to self-administer an anal cancer test was higher if they believed MSM should be screened between 1 and 3 years (87%) rather than screening at other intervals (adjusted odds ratio [aOR] = 2.19; 95% CI, 1.17-4.10) in multivariate analysis (Table 2 ). Willingness was also higher among men who agreed more with the statement: "If I got regular anal pap tests, I would trust them to find anal cancer when it is still treatable." (aOR = 1.47; 95% CI, 1.04-2.09). Additional correlates Three-point scale, decreases chances (coded as 1), has no effect (coded as 2), or increases chances (coded as 3).
e Five-point scale, from strongly disagree (coded as 1) to strongly agree (coded as 5). f Cutoff for high-knowledge was ≥3/5 HPV knowledge items correct, based on median # correct for entire study. of willingness in bivariate analysis were higher worry about anal cancer, higher knowledge about HPV, belief that HIV affects a man's chances of getting anal cancer, being HIV-positive, and being non-Hispanic white when compared with "other" race/ ethnicity (all P < 0.05).
In Study II, willingness to self-administer an anal cancer screening test was higher among men who had higher perceived likelihood of developing anal cancer (aOR = 1.57; 95% CI, 1.12-2.20) in multivariate analysis (Table 3) . In bivariate analyses, correlates of willingness to use a self-test were higher worry about diseases caused by HPV, higher knowledge of HPV, having 5 or more lifetime sexual partners, having a college degree, and being older (all P < 0.05).
DISCUSSION
In the 2 national samples, most gay and bisexual were willing to self-administer an anal cancer screening test at home. The proportion of men willing to use a self-collected test was similar to or higher than those previously reported for physician-collected Pap tests. 16, 24 The possibility that men may prefer a self-collected home test is supported by our findings that Study I men were more willing to use the self-collected test than to get a physiciancollected Pap that cost $150 and that fewer than a third of Study II participants indicated they would rather go to a physician to get screened for anal cancer as a concern about self-testing. This is consistent with the literature on cervical cancer screening, which has shown that allowing women to self-collect HPV samples improves participation in screening programs. 25 Men in Study I were slightly less willing to use a self-collected test than to undergo a physician-collected Pap if offered at no cost. Offering subsidized physician-based testing and promoting home-testing may therefore both be reasonable options to improve screening in the future.
We found much greater willingness to use a self-collected anal cancer screening test than a previous study of acceptability among MSM; Gilbert et al. reported only 35% of men were willing to use a self-collected test, but their sample was limited to men attending MSM-frequented venues and the test was collected in venue bathrooms. 26 The increased privacy, comfort, and safety of collecting the test at home may be important components of men's willingness to self-administer an anal cancer screening test. 27 We identified 3 potentially modifiable correlates of willingness to use self-collected testing in multivariate analyses. Men in Study II who perceived they had a higher likelihood of anal cancer were more willing to self-administer an anal cancer screening test. Reed et al. previously identified this association in their analysis of willingness to get a physician-collected anal Pap test. 16 Multiple health behavior studies have established that risk perceptions, including perceived likelihood, are important predictors of cancer screening participation and other health protective actions. 28 This study extends that link to the use of self-administered cancer screening tests.
Men's willingness to use a self-collected test in Study I was associated with their trust in anal Paps to find cancer when it is still treatable. Belief in the efficacy or benefits of screening is another construct that has been correlated with participation in cancer screening programs. 29 However, Reed et al. did not find a statistically significant association between perceived test efficacy and willingness to get a physician-collected Pap. 17 Similarly, D'Souza et al. found that belief in the use of anal Pap tests was associated with acceptance of a free test among MSM in bivariate analyses, but the association was not significant in their multivariate model. 24 It is possible that test effectiveness is more important to men when considering a home-based test, as a test performed by a physician may be assumed to have some minimal level of effectiveness. This idea is supported by qualitative work showing some people worry that home-based STI tests are less accurate, and our own findings that the majority of men in Study II had concerns about the self-collected test's accuracy and their ability to perform it correctly. 30 The association between believing that MSM should get an anal Pap test to screen for anal cancer and men's willingness to use a self-collected test may simply show that men who thought MSM need to be screened were themselves more willing to be screened. Perceived norms about engaging in health-promoting behavior have been linked to adherence to colorectal cancer screening recommendations. 31 Our study shows that this relationship could also be true for anal cancer screening.
The strengths of this study were its use of 2 large, national samples with high participation rates. To our knowledge, this was the first study to explore gay and bisexual men's willingness to selfadminister an anal cancer screening test using a national sample. Four-point scale, from no chance (coded as 1) to high chance (coded as 4). d Cutoff for high-knowledge was ≥4/5 HPV knowledge items correct, based on median # correct for entire study.
Limitations include the cross-sectional designs and reliance on self-report for the measures, including HIV status and screening history. Study sampling was based on sexual identity rather than behavior and, thus, may not be representative of all MSM. Furthermore, as most men lived in urban areas, had health insurance, and were non-Hispanic white, the generalizability of our findings to other MSM remains to be established. Currently, no self-administered anal cancer screening test is licensed for home use outside of research settings. Our findings for willingness may overestimate men's actual use should such a test become available. Future studies should therefore examine use if a selfadministered home test becomes available. We did not establish whether the participants had access to a provider in their vicinity who offered anal Pap testing or whether it is currently possible to receive a free provider-based test. Both of these factors might reasonably influence men's willingness to undergo such testing relative to a self-collected test. Furthermore, our surveys did not specify whether the home tests were self-collected anal Pap tests, HPV tests, or a combination of the two. If men perceive HPV testing to be more accurate, this might affect their willingness to undergo screening.
CONCLUSIONS
In conclusion, the majority of gay and bisexual men were willing to self-administer an anal cancer screening test at home. If anal Pap tests are shown to be an effective means of reducing incidence and mortality from invasive anal cancer, allowing men the option of home testing could improve screening uptake. This study identified 3 potentially modifiable factors associated with willingness to use a self-test and potential concerns men have with using a self-test that could be targeted in future public health campaigns to increase screening rates.
